Last reviewed · How we verify
NCT05866978: ITASPA
An Integrated Approach to Health, Wellbeing, and Productivity at Work
NA trial testing Integrated Approach to Health, Wellbeing, and Productivity at Work (ITASPA) in Musculoskeletal Disorder in 100 participants. Status unknown.
1 June 2024
Quick facts
| Lead sponsor | Holbaek Sygehus |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | sequential |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 100 |
| Start date | 1 April 2021 |
| Primary completion | 1 June 2024 |
| Estimated completion | 31 December 2024 |
| Sites | 1 location across Denmark |
Drugs / interventions tested
- Integrated Approach to Health, Wellbeing, and Productivity at Work (ITASPA)
Conditions studied
- Musculoskeletal Disorder — all drugs for Musculoskeletal Disorder →
- Mental Health Issue — all drugs for Mental Health Issue →
- Work-related Illness — all drugs for Work-related Illness →
- Safety Issues — all drugs for Safety Issues →
Sponsor
Holbaek Sygehus — full company profile →
Who can join
Adults 18 to 67, any sex, with Musculoskeletal Disorder or Mental Health Issue. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of the workplace intervention study 'An Integrated Approach to Health, Wellbeing, and Productivity at Work (ITASPA)' is to examine the effect of the Australian WorkHealth Improvement Network (WIN) program in a Danish context among blue-collar workers. The project is evaluated via its effect on: 1) Musculoskeletal disorders (MSD), 2) Functionality, 3) Psychosocial wellbeing, and 4) Safety culture. Based on identified work health challenges at the included workplace, a group of employees at each worksite will develop and implement their own health promoting activities. Remaining employees will participate in one screening questionnaire prior to the intervention followed by five health checks and interview based questionnaires. All intervention activities and health checks take place at the participants' workplace during paid working hours. In our study design, participants will be compared to themselves and their previous measurements. Furthermore, we will compare the worksites.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
An integrated approach to health, wellbeing, and productivity at work: a design of a stepped wedge worksite intervention study.
Korshøj M, Poulsen VR, Sköld MB, Autrup SK, et al · · 2023 · cited 2× · PMID 37268907 · DOI 10.1186/s12889-023-16014-x
Verify or expand the search:
- PubMed search for NCT05866978
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Musculoskeletal Disorder
Currently open trials in the same condition.
- NCT05006976 — A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study · NA · active not recruiting
Other Holbaek Sygehus trials
Trials by the same sponsor.
- NCT06022120 — Health Literacy Among Youth · NA · completed
- NCT05250752 — Reduction of Peritoneal Glucose Uptake With Use of SGLT2 in Humans Undergoing Peritoneal Dialysis Treatment · Phase 2 · unknown
- NCT05101473 — Exercise Therapy for People With a Diabetic Foot Ulcer - a Feasibility Study · NA · completed
- NCT04542785 — Lenient Rate Control Versus Strict Rate Control for Atrial Fibrillation. The Danish Atrial Fibrillation Randomised Clini · NA · unknown
- NCT04139876 — Ligasure Hemorrhoidectomy Versus Open Hemorrhoidectomy · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05866978 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Holbaek Sygehus
- Last refreshed: 19 May 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05866978.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing